Drugs / Menogon
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT04537078 Comparator | Sep 2020 → Mar 2021 | female infertility | El Shatby University Hospital for Obstetrics and Gynecology | Completed | No outcome recorded |
| Phase 4 | NCT02330757 Comparator | Oct 2016 → Dec 2024 | infertility disorder | Mansoura University | Unknown | No outcome recorded |
| — | NCT05567731 Background | Oct 2022 → Dec 2023 | infertility disorder | Tanta University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Menogon | “either HMG(Menogon; Ferring, Switzerland) or rFSH (Gonal-f; Merck Serono, Germany)” NCT05567731 ↗ |